Viewing Study NCT01491295

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-02 @ 1:11 PM
Study NCT ID: NCT01491295
Status: UNKNOWN
Last Update Posted: 2016-04-01
First Post: 2011-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
Sponsor: Taipei Veterans General Hospital, Taiwan
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lamivudine View
None adefovir add on treatment View
None tenofovir View
None chronic hepatitis B View